India Court Rejects Cancer Drug Patent Bid - Presented by: The Aol. On Network

Residents in India's capital New Delhi form long queues at this pharmacy. The country is home to a drugs market that grows between 13 and 14 percent every year, making it an attractive investment for Western pharmaceutical companies. But a landmark court ruling could change that. On Monday, India's top court rejected a bid by Swiss drug-maker Novartis to win patent protection for its cancer drug, Glivec.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 14.77 0.21 ▲ 1.44%
VRX $ 32.65 0.71 ▼ 2.13%
F $ 13.62 0.06 ▲ 0.44%
AAPL $ 93.64 0.10 ▼ 0.11%
FCX $ 13.55 0.45 ▼ 3.21%
FTR $ 5.44 0.12 ▼ 2.16%
PFE $ 32.80 0.09 ▲ 0.28%
TVIX $ 3.40 0.43 ▼ 11.23%

As of 5/2/2016, 04:15 PM